Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
45%
AIDS/HIV
32%
Antiretroviral Therapy
42%
Antiretroviral Therapy Initiation
8%
Antiviral Drugs
7%
Background Population
18%
Cancer Risk
10%
Cause of Death
8%
CD4 Cell Count
15%
CD4 Count
11%
Combined Antiretroviral Therapy (cART)
23%
Comorbidity
7%
Comparison Cohort
16%
Confidence Interval
11%
Denmark
46%
Europe
20%
Granulomatosis with Polyangiitis
8%
Greenland
9%
Hazard Ratio
12%
Hepatitis C Virus
9%
Hepatitis C Virus Infection
7%
Highly Active Antiretroviral Therapy (HAART)
31%
HIV Cohort
13%
HIV Diagnosis
11%
HIV Infection
18%
HIV Patients
21%
HIV RNA
7%
HIV-infected Patients
74%
Human Immunodeficiency Virus Type 1 (HIV-1)
31%
Incidence Rate
27%
Infected Individual
13%
Injection Drug Use
9%
Long-term Mortality
16%
Lyme Neuroborreliosis
8%
Matched Cohort Study
16%
Mortality Rate
20%
Myocardial Infarction
7%
National Cohort Study
96%
North America
8%
People Living with HIV (PLHIV)
23%
People Living with Human Immunodeficiency Virus
9%
Population Control
11%
Population-based
9%
Population-based Cohort Study
15%
Protease Inhibitors
7%
Risk Factors
11%
Risk of Death
8%
Viral Load
9%
Virological Failure
13%
Women Living with HIV (WLHIV)
8%
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
5%
Antiretroviral Therapy
22%
Brain Abscess
5%
Cohort Analysis
83%
Diseases
9%
Granulomatosis with Polyangiitis
5%
Hazard Ratio
11%
Highly Active Antiretroviral Therapy
7%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
12%
Infection
10%
Lyme Neuroborreliosis
7%
Malignant Neoplasm
8%
Mortality Rate
11%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
